NeoGenomics Acquisition Expands Oncology Testing Reach
NeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
Read MorePosted by Chris Wolski | Mar 11, 2025 | Company News |
NeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
Read MorePosted by Chris Wolski | Mar 10, 2025 | Cancer |
A new study highlights the role of tsRNAs as potential biomarkers and therapeutic targets for digestive tract diseases.
Read MorePosted by Chris Wolski | Mar 7, 2025 | Diabetes & Metabolic Diseases |
A study highlights that premature menopause significantly increases the risk of Type 2 diabetes, emphasizing the need for early detection.
Read MorePosted by Chris Wolski | Mar 5, 2025 | Molecular Diagnostics |
A gene common in Oceanian populations was missclassified as a cause of heart disease, showing the need for more diverse genomics research.
Read MorePosted by Chris Wolski | Feb 28, 2025 | Lab Automation |
SYNERGEN has embraced AI to help its clinical laboratory customers become more viable and profitable with better reimbursement success.
Read More